Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate and Ketamine in Breast Cancer Surgery
NCT04111848Phase 4Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of magnesium sulfate in postoperative pain (2 arms), sponsored by National Cancer Institute. Primary endpoint: Total amount of morphine required during the first postoperative 24 hours. Started Nov 2019; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04111848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04111848.